Gatza, Erin <br/><br/>
Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Sep 2014 
 - 1426-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2014.05.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Cohort Studies<br/>Etanercept<br/>Female<br/>Glucocorticoids--therapeutic use<br/>Graft vs Host Disease--therapy<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Receptors, Tumor Necrosis Factor--administration & dosage<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Homologous--adverse effects